Jeff Geschwind, MD – Cancer Drug Development Founder of Cage Pharma, Jeff Geschwind, MD focuses on targeting cancer metabolism to create breakthrough drugs. His research on glycolysis inhibition opens new possibilities for treating aggressive tumors. https://www.bumc.bu.edu/camed/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/